KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

ClearPoint Neuro (CLPT) Other Gross PP&E Adjustments (2016 - 2026)

ClearPoint Neuro's Other Gross PP&E Adjustments history spans 14 years, with the latest figure at -$5.4 million for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 378.01% to -$5.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$5.4 million, a 378.01% decrease, with the full-year FY2025 number at -$5.4 million, down 378.01% from a year prior.
  • Other Gross PP&E Adjustments hit -$5.4 million in Q4 2025 for ClearPoint Neuro, up from -$6.0 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for CLPT hit a ceiling of -$911000.0 in Q4 2022 and a floor of -$6.1 million in Q2 2025.
  • Historically, Other Gross PP&E Adjustments has averaged -$3.0 million across 5 years, with a median of -$2.8 million in 2021.
  • Biggest five-year swings in Other Gross PP&E Adjustments: tumbled 702.83% in 2021 and later skyrocketed 67.05% in 2024.
  • Tracing CLPT's Other Gross PP&E Adjustments over 5 years: stood at -$1.9 million in 2021, then surged by 51.95% to -$911000.0 in 2022, then crashed by 275.74% to -$3.4 million in 2023, then skyrocketed by 67.05% to -$1.1 million in 2024, then tumbled by 378.01% to -$5.4 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for CLPT at -$5.4 million in Q4 2025, -$6.0 million in Q3 2025, and -$6.1 million in Q2 2025.